Cargando…
Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies
The development of drugs to improve cognition in patients with schizophrenia is a major unmet clinical need. A number of promising compounds failed in recent clinical trials, a pattern linked to poor translation between preclinical and clinical stages of drug development. Seeking proof of efficacy i...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070057/ https://www.ncbi.nlm.nih.gov/pubmed/27187233 http://dx.doi.org/10.1038/tp.2016.64 |